FTC finds PBMs excessively marked up prices on specialty drugs

CVS Health Caremark Corporate Office in Irving, Texas, USA.

JHVEPhoto

A new report issued by the Federal Trade Commission has found that prescription benefit manager units owned by CVS Health (NYSE:CVS), Cigna (CI) and UnitedHealth Group (UNH) significantly marked up prices for many specialty generic

Leave a Reply

Your email address will not be published. Required fields are marked *